DK452485D0 - Farmaceutisk praeparat indeholdende interferon-gamma (ifn-gamma) - Google Patents

Farmaceutisk praeparat indeholdende interferon-gamma (ifn-gamma)

Info

Publication number
DK452485D0
DK452485D0 DK452485A DK452485A DK452485D0 DK 452485 D0 DK452485 D0 DK 452485D0 DK 452485 A DK452485 A DK 452485A DK 452485 A DK452485 A DK 452485A DK 452485 D0 DK452485 D0 DK 452485D0
Authority
DK
Denmark
Prior art keywords
gamma
pharmaceutical preparation
preparation containing
containing interferon
ifn
Prior art date
Application number
DK452485A
Other languages
English (en)
Other versions
DK174585B1 (da
DK452485A (da
Inventor
Josef Dr Brzoska
Johann-Friedrich Von Eichborn
Hans-Joachim Dr Obert
Original Assignee
Bioferon Biochem Substanz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27192400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK452485(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19843436637 external-priority patent/DE3436637A1/de
Priority claimed from DE3436638A external-priority patent/DE3436638C2/de
Priority claimed from DE19853521733 external-priority patent/DE3521733A1/de
Application filed by Bioferon Biochem Substanz filed Critical Bioferon Biochem Substanz
Publication of DK452485D0 publication Critical patent/DK452485D0/da
Publication of DK452485A publication Critical patent/DK452485A/da
Application granted granted Critical
Publication of DK174585B1 publication Critical patent/DK174585B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198504524A 1984-10-05 1985-10-04 Anvendelse af gamma-inteferon til fremstilling af farmaceutiske præparater til systemisk behandling af forskellige sygdomme hos mennesker i lave doser DK174585B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE19843436637 DE3436637A1 (de) 1984-10-05 1984-10-05 Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur behandlung von schmerzen
DE3436638A DE3436638C2 (de) 1984-10-05 1984-10-05 Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur Behandlung rheumatischer Erkrankungen
DE3436638 1984-10-05
DE3436637 1984-10-05
DE3521733 1985-06-18
DE19853521733 DE3521733A1 (de) 1985-06-18 1985-06-18 Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von tumoren und viruserkrankungen in niedriger dosierung

Publications (3)

Publication Number Publication Date
DK452485D0 true DK452485D0 (da) 1985-10-04
DK452485A DK452485A (da) 1986-04-06
DK174585B1 DK174585B1 (da) 2003-07-07

Family

ID=27192400

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198504524A DK174585B1 (da) 1984-10-05 1985-10-04 Anvendelse af gamma-inteferon til fremstilling af farmaceutiske præparater til systemisk behandling af forskellige sygdomme hos mennesker i lave doser

Country Status (6)

Country Link
US (1) US5145677A (da)
EP (2) EP0181455B2 (da)
CA (1) CA1288694C (da)
DE (1) DE3583849D1 (da)
DK (1) DK174585B1 (da)
IL (2) IL76591A0 (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149551A3 (en) * 1984-01-16 1987-09-23 Genentech, Inc. Gamma interferon-interleukin-2 synergistic compositions and processes therefor
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
GB8522336D0 (en) * 1985-09-09 1985-10-16 Biogen Nv Composition for treatment of allergies
JPH01501792A (ja) * 1986-03-17 1989-06-22 シェリング・コーポレーション γ型インターフェロンによる癌の治療
ATE67675T1 (de) * 1986-06-17 1991-10-15 Biogen Inc Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten.
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma
CA1320905C (en) 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
EP0278715A3 (en) * 1987-02-09 1989-03-08 Schering Corporation Use of human gamma interferon for treatment of basal cell carcinoma
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
WO1989008461A1 (en) * 1988-03-07 1989-09-21 Centocor, Inc. Interferon gamma composition to suppress immune system
FR2644067B1 (fr) * 1989-02-02 1993-02-05 Roussel Uclaf Utilisation de certains interferons gamma pour la preparation de compositions pharmaceutiques destinees au traitement du cancer de l'ovaire par voie intraperitoneale
EP0502997B1 (en) * 1989-12-01 1995-05-03 Children's Medical Center Corporation Use of gamma-interferon for the manufacture of a medicament in the treatment of steroid dependent asthma
US5849282A (en) * 1990-05-09 1998-12-15 Otsuka Pharmaceutical Co., Ltd. Method of treating colon, renal, and lung carcinomas with γ-interferon and Ser71 !-interleukin-1β
JP2587711B2 (ja) * 1990-05-09 1997-03-05 大塚製薬 株式会社 抗腫瘍剤
US5681555A (en) * 1991-04-22 1997-10-28 Gleich; Gerald J. Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
TW218846B (da) * 1992-04-07 1994-01-11 Ciba Geigy
EP0704220A1 (de) * 1994-09-30 1996-04-03 Dr. Rentschler Biotechnologie GmbH Verwendung von Interferon beta enthaltenden Arzneimitteln
JP3834084B2 (ja) * 1995-09-07 2006-10-18 第一アスビオファーマ株式会社 痒疹治療剤
ATE262920T1 (de) 1995-11-02 2004-04-15 Schering Corp Kontinuierliche, niedrigdosierte zytokine- infusionstherapie
US6509313B1 (en) 1996-02-28 2003-01-21 Cornell Research Foundation, Inc. Stimulation of immune response with low doses of cytokines
AUPN976596A0 (en) * 1996-05-09 1996-05-30 Pharma Pacific Pty Ltd Stimulation of host defence mechanisms
ATE316792T1 (de) * 1996-05-09 2006-02-15 Pharma Pacific Pty Ltd Stimulierung wirtseigener abwehrmechanismen gegen krebs
US20030108519A1 (en) * 1996-05-09 2003-06-12 Pharma Pacific Pty Ltd. Therapeutic applications of high dose in terferon
EP2990054A1 (en) * 1998-08-11 2016-03-02 Biogen Inc. Combination therapies for B-cell lyphomas comprising administration of anti-CD20 antibody
CA2350064C (en) * 1998-11-09 2012-05-08 Idec Pharmaceuticals Corporation Chimeric anti-cd20 antibody treatment of patients receiving bmt or pbsc transplants
US20040228871A1 (en) * 1999-06-03 2004-11-18 Tayyaba Hasan Treatment and analysis of proliferative disorders
EP1066834A3 (de) * 1999-07-08 2004-06-02 Thomas Dr. Stief Pharmazeutische Zusammensetzungen enthaltend ein phagozytenmodulierendes Agens
US8557244B1 (en) 1999-08-11 2013-10-15 Biogen Idec Inc. Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
CA2387089A1 (en) * 1999-11-10 2001-05-17 Mondobiotech Sa Interferon gamma for the treatment of asthma
DE60021760T2 (de) 1999-12-09 2006-06-08 Chiron Corp., Emeryville Verfahren zur verabreichung von wirkstoffen in das zentrale nervensystem oder lymphsystem
EP1307220A4 (en) * 2000-03-31 2004-06-16 Aronex Pharmaceuticals Inc COMBINATION OF INTERFERON ALPHA AND ALL-TRANS-RETINIC ACID INCLUDED IN LIPOSOMES, THEIR PREPARATION AND USE
AU2001297807A1 (en) * 2000-12-20 2002-11-11 Sri International Modulators of the hypocretin system and methods of screening therefor
EP1404366A4 (en) * 2001-06-14 2006-06-07 Intermune Inc COMBINED THERAPY USING INTERFERON GAMMA AND SPECIFIC B-CELL ANTIBODIES
IL159784A0 (en) * 2001-07-20 2004-06-20 Intermune Inc Methods of treating liver fibrosis
US6911198B2 (en) * 2001-09-17 2005-06-28 Yeda Research And Development Co. Ltd. Method and pharmaceutical composition for treating inflammation
PL371683A1 (en) * 2001-10-05 2005-06-27 Intermune, Inc. Methods of treating liver fibrosis and hepatitis c virus infection
CN100536852C (zh) * 2002-07-15 2009-09-09 基利得科学公司 L-fmau在制备联合治疗乙型肝炎病毒感染的药物中的应用
CA2496577A1 (en) * 2002-08-28 2004-03-11 Intermune, Inc. Combination therapy for treatment of fibrotic disorders
EP1430902A1 (en) * 2002-12-20 2004-06-23 Mondobiotech Laboratories Anstalt Pharmaceutical composition of interferon gamma with molecular diagnostics for the improved treatment of asthma bronchiale
US7449177B2 (en) * 2002-12-26 2008-11-11 Asubio Pharma Co., Ltd. Remedy for pemphigoid
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
CA3138094A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
TW202146041A (zh) * 2020-03-06 2021-12-16 尼姆大學醫學中心 用於肌肉萎縮性脊髓側索硬化症之治療的低劑量人類介白素-2
WO2023072877A1 (en) * 2021-10-25 2023-05-04 Ellennbe Gmbh Pharmaceutical composition and kit comprising an immunomodulatory substance for treating diseases

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
US4460685A (en) 1980-05-29 1984-07-17 New York University Method of enhancing the production of human γ Interferon
US4460574A (en) * 1980-06-16 1984-07-17 Yabrov Alexander A Prophylaxis or treatment of interferon-sensitive diseases
US4376821A (en) 1981-04-17 1983-03-15 Meloy Laboratories, Inc. Production of human IFN-gamma (immune) interferon
WO1983001198A1 (en) * 1981-10-08 1983-04-14 Kurt Frimann Berg Method and composition for treating a patient suffering from interferon-susceptible disorder
EP0077063B1 (en) 1981-10-13 1988-03-16 Exovir, Inc. Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
EP0080032A3 (en) 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmaceutical preparation for treating herpetic lesions
EP0088540A3 (en) * 1982-02-22 1984-10-17 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
DE3381553D1 (de) * 1982-10-25 1990-06-21 Genentech Inc Synergistische humaninterferonaktivitaet.
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
IL67896A (en) * 1983-02-13 1987-03-31 Yeda Res & Dev Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
US4461757A (en) 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
ZA844070B (en) * 1983-06-01 1984-12-24 Genentech Inc Gamma interferon-lymphotoxin synergism
CA1265444A (en) * 1983-06-27 1990-02-06 Lloyd J. Old Effect of human tumor necrosis factor and human interferon on human cancer cells and methods
EP0149551A3 (en) * 1984-01-16 1987-09-23 Genentech, Inc. Gamma interferon-interleukin-2 synergistic compositions and processes therefor
US4946674A (en) * 1984-10-05 1990-08-07 Bioferon Biochemische Substanzen Gmbh & Co. Process for treatment of rheumatic diseases
FR2611031B1 (fr) * 1987-02-16 1989-05-05 Commissariat Energie Atomique Refrigerateur, notamment a cycle de vuilleumier, comportant des pistons suspendus par des paliers a gaz

Also Published As

Publication number Publication date
US5145677A (en) 1992-09-08
DK174585B1 (da) 2003-07-07
EP0181455A3 (en) 1986-06-04
DK452485A (da) 1986-04-06
AU4841285A (en) 1986-04-10
DE3583849D1 (de) 1991-09-26
EP0181455A2 (de) 1986-05-21
EP0177910A3 (de) 1986-07-02
IL76591A (en) 1991-06-10
EP0181455B2 (de) 2000-05-31
IL76591A0 (en) 1986-02-28
AU588547B2 (en) 1989-09-21
CA1288694C (en) 1991-09-10
EP0177910A2 (de) 1986-04-16
EP0181455B1 (de) 1991-08-21

Similar Documents

Publication Publication Date Title
DK452485A (da) Farmaceutisk praeparat indeholdende interferon-gamma (ifn-gamma)
MC1782A1 (fr) Preparation pharmaceutique
DK481585A (da) Farmaceutisk praeparat indeholdende anthracyclinglycosider
DK28985A (da) Stabilt humant gamma-interferonpraeparat samt fremgangsmaade til fremstilling deraf
IL80032A (en) Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them
KR890701135A (ko) 감마 인터페론 제제
DK259186A (da) Nasale farmaceutiske praeparater
IL79376A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
AU6397986A (en) Derivatives of gamma ifn
DK131986A (da) Stabilt gammainterferonpraeparat
NZ215910A (en) Cyclopentyl ethers and pharmaceutical compositions
DK52086D0 (da) Farmaceutiske praeparater indeholdende ergotalkaloider
GB8500310D0 (en) Pharmaceutical preparation
GB8623389D0 (en) Pharmaceutical formulations
IL77594A (en) 2-substituted-3,4-dihydroxyphenethylamine derivatives,their preparation and pharmaceutical compositions containing them
IL79003A0 (en) Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them
GB2184119B (en) Preparation of aliphatic tertiary amines
IL79377A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
IL78918A0 (en) Substituted hexahydro-arylquinolizines and pharmaceutical compositions containing them
IL74168A (en) 1alpha-hydroxyvitamin d2 analogs and pharmaceutical compositions containing them
IL79535A0 (en) Acylphosphorotriamides and pharmaceutical compositions containing them
ZA862140B (en) Stable gamma interferon formulation
IL80379A0 (en) Gonadoliberine analogues,their preparation and pharmaceutical compositions containing them
AU6605686A (en) Bovine gamma ifn
IL80338A0 (en) Bicycle-substituted phenylacetonitrile derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
A0 Application filed
PUP Patent expired